EU ingredient rules · 1 min read

Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate in cosmetics: EU rules

Quick answer: Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate is an approved UV filter in the EU (Annex VI, entry 32), at up to 3% in the ready-to-use product. CosIng lists its functions as light stabilizer and UV filter.

Key facts

Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate at a glance
INCI nameMETHOXYPROPYLAMINO CYCLOHEXENYLIDENE ETHOXYETHYLCYANOACETATE
CAS number1419401-88-9
EU statusPermitted UV filter (Annex VI, entry 32)
Functions (CosIng)Light stabilizer, UV filter

CosIng description: Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate is the organic compound

What it does in a product

  • Light stabilizer: Protects the formula itself from being broken down by light.
  • UV filter: Filters UV rays to help protect the skin from sunlight.

Annex VI: permitted UV filters, entry 32

Annex VI is the list of UV filters allowed in cosmetic products in the EU, each with a maximum concentration. A substance used mainly to protect the skin from UV light must be on this list.

The entry is listed as 2-ethoxyethyl (2Z)-2-cyano-2-[3-(3-methoxypropylamino) cyclohex-2-en-1-ylidene]acetate

Maximum concentration in the ready-to-use product: 3%

Other conditions:

Most recent legal act listed by CosIng for this entry: Regulation (EU) 2020/1684.

Scientific Committee on Consumer Safety (SCCS) opinions:

Why it matters for shelf life

UV filters are what give a sunscreen its stated protection. Sunscreen carries an expiry date because that protection is only guaranteed until then, and heat can break the formula down sooner.

Not sure how to read a label? What an INCI name is · How ingredient lists work

Source

European Commission, CosIng (Cosmetic Ingredients database), entries for METHOXYPROPYLAMINO CYCLOHEXENYLIDENE ETHOXYETHYLCYANOACETATE and Annex VI/32, retrieved 2026-10-11. CosIng is provided for information only and has no legal value; the legally binding text is Regulation (EC) No 1223/2009 and its amendments as published in the Official Journal of the European Union. Rules outside the EU, for example in the US, can differ. This page is not legal or medical advice.